L-165,041 is a small molecule agonist of the phenyloxyacetate PPAR-delta receptor (Ki=6nM), >100-fold selective vs other PPAR receptors. Has neuroprotective properties in cerebral infarction and Parkinson's disease. It is less potent and selective than GlaxoSmithKline's other PPARδ inhibitor, GW 501516.